IDIOPATHIC PULMONARY FIBROSIS (IPF)
Clinical trials for IDIOPATHIC PULMONARY FIBROSIS (IPF) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PULMONARY FIBROSIS (IPF) trials appear
Sign up with your email to follow new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled drug for lung scarring enters early human testing
Disease control CompletedThis early-stage trial is testing an inhaled form of nintedanib (called MNKD-201) in 24 people with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs. The study aims to see if the drug is safe and tolerable when breathed in, and how the body processes it. Partic…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Phase: PHASE1 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New pill for scarred lungs shows promise in early trial
Disease control CompletedThis study tested an experimental oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The main goal was to see if the drug is safe and tolerable over 12 weeks compared to a placebo. Resea…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
AI could uncover hidden lung disease in routine chest X-Rays
Diagnosis CompletedThis study evaluates an artificial intelligence (AI) software that analyzes chest X-rays to detect signs of interstitial lung disease (ILD), a group of conditions that scar the lungs. Researchers are checking how often the AI's flags for lung abnormalities turn out to be real dis…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Chung-Ang University Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New study tests arm strength as a window into IPF Patients' daily struggles
Knowledge-focused CompletedThis study looked at 21 adults with idiopathic pulmonary fibrosis (IPF) to see how a simple arm test (the 6-minute pegboard and ring test) relates to their exercise ability, fatigue, daily activities, and quality of life. Participants performed several physical tests, including w…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Muscle weakness linked to worse outcomes in lung disease patients
Knowledge-focused CompletedThis completed study looked at 60 people with idiopathic pulmonary fibrosis (IPF) to see how common muscle loss (sarcopenia) is and how it affects their quality of life and disease progression. Researchers measured muscle strength, walking speed, lung function, and used a questio…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Mersin University • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:41 UTC